Regulatory submissions to the U.S. FDA for
NDAs, BLAs, and ANDAs must be
submitted in electronic Common Technical
Document (eCTD) format. This
requirement has been in place since May
5, 2017, per the timeline set forth in the
“umbrella” guidance (1).